Journal of the American Society of Nephrology, Vol 5, 1675-1683, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis

E Engelmyer, H van Goor, DR Edwards and JR Diamond
Department of Surgery, Milton S. Hershey Medical Center, Hershey, PA 17033, USA.

The pathophysiologic sequelae of both acute and chronic experimental unilateral ureteral obstruction (UUO) in the rat are the result of a variety of complex humoral and cellular interactions. The development of interstitial fibrosis is dependent on the tightly coupled regulation of synthesis and degradation of extracellular matrix proteins. This laboratory, among others, has shown an up-regulated expression of renal cortical transforming growth factor (TGF)-beta 1 within hours of the onset of UUO. Because a potential contribution of TGF-beta to fibrosis may be its ability to increase the expression of proteinase inhibitors such as members of the tissue inhibitor of metalloproteinase (TIMP) family, this laboratory now sought to delineate the kinetics of TIMP-1, TIMP-2, and TIMP-3 mRNA expression in the renal cortex after UUO. There was a marked elevation of TIMP-1 mRNA expression after UUO, which was first noted at 12 h after ureteral ligation. By 96 h after UUO; there was a 30-fold increment in TIMP-1 mRNA in the obstructed kidneys compared with the contralateral unobstructed kidney or sham-operated rat specimens. In contradistinction to TIMP-1, a decrease in TIMP-3 mRNA levels was noted at 12 h after ureteral obstruction and persisted at the 24-, 48-, and 96-h time intervals. TIMP-2 gene expression remained at a relatively constant level during the entire study. It is proposed that the increased expression of TGF-beta 1 post-UUO induces a profibrogenic state and initiates a cascade of dysregulatory events including the up-regulation of TIMP-1.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. H. Horstrup, M. Gehrmann, B. Schneider, A. Ploger, P. Froese, T. Schirop, D. Kampf, U. Frei, R. Neumann, and K.-U. Eckardt Elevation of serum and urine levels of TIMP-1 and tenascin in patients with renal disease Nephrol. Dial. Transplant., June 1, 2002; 17(6): 1005 - 1013. [Abstract] [Full Text] [PDF]

				H. KIM, T. ODA, J. LOPEZ-GUISA, D. WING, D. R. EDWARDS, P. D. SOLOWAY, and A. A. EDDY TIMP-1 Deficiency Does Not Attenuate Interstitial Fibrosis in Obstructive Nephropathy J. Am. Soc. Nephrol., April 1, 2001; 12(4): 736 - 748. [Abstract] [Full Text] [PDF]

				S. Lavaud, B. Poirier, C. Mandet, M.-F. Belair, T. Irinopoulou, D. Heudes, R. Bazin, J. Bariety, I. Myara, and J. Chevalier Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats Am J Physiol Renal Physiol, April 1, 2001; 280(4): F683 - F694. [Abstract] [Full Text] [PDF]

				O. LENZ, S. J. ELLIOT, and W. G. STETLER-STEVENSON Matrix Metalloproteinases in Renal Development and Disease J. Am. Soc. Nephrol., March 1, 2000; 11(3): 574 - 581. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673